08:44 AM EDT, 06/07/2024 (MT Newswires) -- Health care stocks were leaning lower pre-bell Friday with the Health Care Select Sector SPDR Fund (XLV) down 0.4% and the iShares Biotechnology ETF (IBB) recently declining by 0.7%.

Geron ( GERN ) rallied past 16% after saying it received approval from the US Food and Drug Administration for its drug Rytelo as a treatment of adult patients with lower-risk myelodysplastic syndrome, a type of leukemia.